Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00600587 · COMPLETED

Trial details

NCT number: NCT00600587
Sponsor: Guangdong Provincial People's Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2007-09-01
Primary completion: 2013-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.